[Fotemustine (Muphoran) in 22 patients with relapses of high-grade cerebral gliomas]
about
Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylationA new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma.Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastomaFotemustine: a third-generation nitrosourea for the treatment of recurrent malignant gliomas.The 1,4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells.
P2860
[Fotemustine (Muphoran) in 22 patients with relapses of high-grade cerebral gliomas]
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
[Fotemustine (Muphoran) in 22 patients with relapses of high-grade cerebral gliomas]
@ast
[Fotemustine (Muphoran) in 22 patients with relapses of high-grade cerebral gliomas]
@en
[Fotemustine
@nl
type
label
[Fotemustine (Muphoran) in 22 patients with relapses of high-grade cerebral gliomas]
@ast
[Fotemustine (Muphoran) in 22 patients with relapses of high-grade cerebral gliomas]
@en
[Fotemustine
@nl
prefLabel
[Fotemustine (Muphoran) in 22 patients with relapses of high-grade cerebral gliomas]
@ast
[Fotemustine (Muphoran) in 22 patients with relapses of high-grade cerebral gliomas]
@en
[Fotemustine
@nl
P2093
P1433
P1476
[Fotemustine (Muphoran) in 22 patients with relapses of high-grade cerebral gliomas]
@en
P2093
P304
P577
1999-03-01T00:00:00Z